Wei-Chun Chang

Title: Wei-Chun Chang: Innovator in Cell Therapy

Introduction

Wei-Chun Chang is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of modified Caspase polypeptides. With a total of 2 patents, his work is paving the way for advancements in cell therapy.

Latest Patents

Chang's latest patents focus on modified Caspase-9 polypeptides and their applications. The technology involves compositions that include modified Caspase-9 polypeptides and nucleic acids coding for these polypeptides. Additionally, it encompasses chimeric modified Caspase-9 polypeptides and methods for their use, particularly in cell therapy. These methods include the modification of transfused cells to express an inducible modified Caspase-9 protein, which has reduced basal activity in the absence of an inducer.

Career Highlights

Wei-Chun Chang is currently associated with Bellicum Pharmaceuticals, Inc., where he continues to innovate in the field of biotechnology. His work is instrumental in advancing therapeutic techniques that could potentially transform patient care.

Collaborations

Chang collaborates with various professionals in his field, including his coworker David Spencer. Their combined expertise contributes to the ongoing research and development efforts at Bellicum Pharmaceuticals.

Conclusion

Wei-Chun Chang's contributions to the field of biotechnology, particularly through his patents on modified Caspase polypeptides, highlight his role as an innovator in cell therapy. His work promises to enhance therapeutic options for patients in need.